• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于快速鉴定结核分枝杆菌gyrA基因突变的新型线性探针检测法的评估

Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis.

作者信息

Giannoni Federico, Iona Elisabetta, Sementilli Federica, Brunori Lara, Pardini Manuela, Migliori Giovanni Battista, Orefici Graziella, Fattorini Lanfranco

机构信息

Dipartimento di Malattie Infettive, Parassitarie e Immunomediate, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.

出版信息

Antimicrob Agents Chemother. 2005 Jul;49(7):2928-33. doi: 10.1128/AAC.49.7.2928-2933.2005.

DOI:10.1128/AAC.49.7.2928-2933.2005
PMID:15980370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1168684/
Abstract

Resistance of Mycobacterium tuberculosis to fluoroquinolones (FQ) results mostly from mutations in the gyrA gene. We developed a reverse hybridization-based line probe assay in which oligonucleotide probes carrying the wild-type gyrA sequence, a serine-to-threonine (S95T) polymorphism, and gyrA mutations (A90V, A90V-S95T, S91P, S91P-S95T, D94A, D94N, D94G-S95T, D94H-S95T) were immobilized on nitrocellulose strips and hybridized with digoxigenin-labeled PCR products obtained from M. tuberculosis strains. When a mutated PCR product was used, hybridization occurred to the corresponding mutated probe but not to the wild-type probe. A panel of M. tuberculosis complex strains including 19 ofloxacin-resistant (OFL-R) and 9 ofloxacin-susceptible (OFL-S) M. tuberculosis strains was studied for detection and identification of gyrA mutations by the line probe assay and nucleotide sequencing, in comparison with testing of in vitro susceptibility to FQ. Results were 100% concordant with those of nucleotide sequencing. The S95T polymorphism, which is not related to FQ resistance, was found in 5 OFL-S and 2 OFL-R strains; the other 17 OFL-R strains harbored single mutations associated with serine or threonine at codon 95. No mutations were found in the other OFL-S strains. Overall, on the basis of the MICs on solid medium, the new line probe assay correctly identified all OFL-S and 17 out of 19 (89.5%) OFL-R strains. A nested-PCR protocol was also evaluated for the assay to amplify PCR products from M. tuberculosis-spiked sputa, with a good specificity and a sensitivity of 2 x 10(3) M. tuberculosis CFU per ml of sputum.

摘要

结核分枝杆菌对氟喹诺酮类药物(FQ)的耐药性主要源于gyrA基因突变。我们开发了一种基于反向杂交的线性探针检测法,其中携带野生型gyrA序列、丝氨酸到苏氨酸(S95T)多态性以及gyrA突变(A90V、A90V - S95T、S91P、S91P - S95T、D94A、D94N、D94G - S95T、D94H - S95T)的寡核苷酸探针被固定在硝酸纤维素膜条上,并与从结核分枝杆菌菌株获得的地高辛标记的PCR产物杂交。当使用突变的PCR产物时,杂交发生在相应的突变探针上,而不是野生型探针上。通过线性探针检测法和核苷酸测序,对一组包括19株耐氧氟沙星(OFL - R)和9株对氧氟沙星敏感(OFL - S)的结核分枝杆菌复合群菌株进行了gyrA突变的检测和鉴定,并与体外对FQ的敏感性测试进行了比较。结果与核苷酸测序结果100%一致。在5株OFL - S和2株OFL - R菌株中发现了与FQ耐药性无关的S95T多态性;其他17株OFL - R菌株在密码子95处存在与丝氨酸或苏氨酸相关的单突变。在其他OFL - S菌株中未发现突变。总体而言,基于固体培养基上的最低抑菌浓度,新的线性探针检测法正确鉴定了所有OFL - S菌株和19株OFL - R菌株中的17株(89.5%)。还对该检测法的巢式PCR方案进行了评估,以从接种了结核分枝杆菌的痰液中扩增PCR产物,其具有良好的特异性,每毫升痰液对2×10³个结核分枝杆菌CFU的灵敏度。

相似文献

1
Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis.一种用于快速鉴定结核分枝杆菌gyrA基因突变的新型线性探针检测法的评估
Antimicrob Agents Chemother. 2005 Jul;49(7):2928-33. doi: 10.1128/AAC.49.7.2928-2933.2005.
2
Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China.中国湖北省结核分枝杆菌临床分离株中 gyrA 和 gyrB 突变与氟喹诺酮类耐药性的特征。
Braz J Infect Dis. 2012 Mar-Apr;16(2):136-41. doi: 10.1016/s1413-8670(12)70294-5.
3
Molecular detection of fluoroquinolone resistance-associated gyrA mutations in ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Iran and Belarus.伊朗和白俄罗斯耐氧氟沙星结核分枝杆菌临床分离株中氟喹诺酮耐药相关gyrA基因突变的分子检测
Int J Mycobacteriol. 2016 Sep;5(3):299-305. doi: 10.1016/j.ijmyco.2016.07.004. Epub 2016 Aug 3.
4
Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.多重PCR扩增子构象分析用于快速检测耐氟喹诺酮结核分枝杆菌临床分离株中的gyrA突变
Antimicrob Agents Chemother. 2004 Feb;48(2):596-601. doi: 10.1128/AAC.48.2.596-601.2004.
5
Double mutation in DNA gyrase confers moxifloxacin resistance and decreased fitness of Mycobacterium smegmatis.DNA 回旋酶的双突变赋予了莫西沙星耐药性,并降低了耻垢分枝杆菌的适应性。
J Antimicrob Chemother. 2017 Jul 1;72(7):1893-1900. doi: 10.1093/jac/dkx110.
6
Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.氟喹诺酮类耐药结核分枝杆菌临床分离株的分子特征。
Diagn Microbiol Infect Dis. 2012 Jul;73(3):260-3. doi: 10.1016/j.diagmicrobio.2012.03.025. Epub 2012 May 4.
7
Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant Mycobacterium tuberculosis isolates.主动外排泵抑制剂对氧氟沙星耐药结核分枝杆菌分离株药物敏感性的影响。
Indian J Med Res. 2011 May;133(5):535-40.
8
Evaluation of a line probe assay for the rapid detection of gyrA mutations associated with fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis.评估一种线探针检测法,用于快速检测与氟喹诺酮类药物耐药相关的多重耐药结核分枝杆菌gyrA 突变。
J Med Microbiol. 2011 Feb;60(Pt 2):184-188. doi: 10.1099/jmm.0.024729-0. Epub 2010 Nov 4.
9
Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.gyrB基因突变在泰国临床分离株的广泛耐药和超级耐药结核病中的作用
Antimicrob Agents Chemother. 2016 Aug 22;60(9):5189-97. doi: 10.1128/AAC.00539-16. Print 2016 Sep.
10
Genotypic detection of fluoroquinolone resistance in drug-resistant Mycobacterium tuberculosis at a tertiary care centre in south Coastal Karnataka, India.印度卡纳塔克邦南部沿海一家三级护理中心耐氟喹诺酮类结核分枝杆菌的基因型耐药检测。
J Glob Antimicrob Resist. 2018 Jun;13:250-253. doi: 10.1016/j.jgar.2018.01.023. Epub 2018 Feb 5.

引用本文的文献

1
Moxifloxacin Activates the SOS Response in in a Dose- and Time-Dependent Manner.莫西沙星以剂量和时间依赖性方式激活SOS反应。
Microorganisms. 2021 Jan 27;9(2):255. doi: 10.3390/microorganisms9020255.
2
Fluoroquinolone resistance and mutational profile of gyrA in pulmonary MDR tuberculosis patients.氟喹诺酮类耐药与肺部耐多药结核患者gyrA 突变特征。
BMC Pulm Med. 2020 May 11;20(1):138. doi: 10.1186/s12890-020-1172-4.
3
Fluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations.结核分枝杆菌氟喹诺酮类药物异质性耐药:通过实验混合人群的基因和表型检测方法的检测。
Sci Rep. 2019 Aug 13;9(1):11760. doi: 10.1038/s41598-019-48289-9.
4
Sequence Analysis of Fluoroquinolone Resistance-Associated Genes gyrA and gyrB in Clinical Mycobacterium tuberculosis Isolates from Patients Suspected of Having Multidrug-Resistant Tuberculosis in New Delhi, India.印度新德里疑似耐多药结核病患者临床结核分枝杆菌分离株中氟喹诺酮耐药相关基因gyrA和gyrB的序列分析
J Clin Microbiol. 2016 Sep;54(9):2298-305. doi: 10.1128/JCM.00670-16. Epub 2016 Jun 22.
5
A molecular platform for the diagnosis of multidrug-resistant and pre-extensively drug-resistant tuberculosis based on single nucleotide polymorphism mutations present in Colombian isolates of Mycobacterium tuberculosis.基于哥伦比亚结核分枝杆菌分离株中存在的单核苷酸多态性突变,用于诊断耐多药和广泛耐药前结核病的分子平台。
Mem Inst Oswaldo Cruz. 2016 Feb;111(2):93-100. doi: 10.1590/0074-02760150306. Epub 2016 Feb 2.
6
Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.临床结核分枝杆菌分离株中与氟喹诺酮耐药相关的gyrA和gyrB基因突变的频率及地理分布:一项系统评价
PLoS One. 2015 Mar 27;10(3):e0120470. doi: 10.1371/journal.pone.0120470. eCollection 2015.
7
Integrated microfluidic card with TaqMan probes and high-resolution melt analysis to detect tuberculosis drug resistance mutations across 10 genes.集成有TaqMan探针和高分辨率熔解分析的微流控芯片,用于检测10个基因的结核耐药性突变
mBio. 2015 Feb 24;6(2):e02273. doi: 10.1128/mBio.02273-14.
8
Molecular epidemiology and clinical characteristics of drug-resistant Mycobacterium tuberculosis in a tuberculosis referral hospital in China.中国一家结核病转诊医院耐药结核分枝杆菌的分子流行病学及临床特征
PLoS One. 2014 Oct 10;9(10):e110209. doi: 10.1371/journal.pone.0110209. eCollection 2014.
9
Evaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of Mycobacterium tuberculosis.评估MGIT 960系统用于结核分枝杆菌二线药物敏感性检测
Tuberc Res Treat. 2013;2013:108401. doi: 10.1155/2013/108401. Epub 2013 Mar 28.
10
New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations.结核分枝杆菌氟喹诺酮类耐药的新认识:gyrA 和 gyrB 突变的功能遗传分析。
PLoS One. 2012;7(6):e39754. doi: 10.1371/journal.pone.0039754. Epub 2012 Jun 28.

本文引用的文献

1
Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity.结核分枝杆菌DNA回旋酶:与喹诺酮类药物的相互作用及其与抗分枝杆菌药物活性的相关性。
Antimicrob Agents Chemother. 2004 Apr;48(4):1281-8. doi: 10.1128/AAC.48.4.1281-1288.2004.
2
Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis.205例耐多药结核病患者的治疗与转归分析
Am J Respir Crit Care Med. 2004 May 15;169(10):1103-9. doi: 10.1164/rccm.200308-1159OC. Epub 2004 Jan 23.
3
Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.多重PCR扩增子构象分析用于快速检测耐氟喹诺酮结核分枝杆菌临床分离株中的gyrA突变
Antimicrob Agents Chemother. 2004 Feb;48(2):596-601. doi: 10.1128/AAC.48.2.596-601.2004.
4
The rapid development of fluoroquinolone resistance in M. tuberculosis.结核分枝杆菌对氟喹诺酮耐药性的快速发展。
N Engl J Med. 2003 Nov 13;349(20):1977-8. doi: 10.1056/NEJM200311133492023.
5
Fluoroquinolone-containing third-line regimen against Mycobacterium tuberculosis in vivo.含氟喹诺酮的三线抗结核分枝杆菌体内治疗方案。
Antimicrob Agents Chemother. 2003 Oct;47(10):3117-22. doi: 10.1128/AAC.47.10.3117-3122.2003.
6
Fluoroquinolones, tuberculosis, and resistance.氟喹诺酮类、结核病与耐药性。
Lancet Infect Dis. 2003 Jul;3(7):432-42. doi: 10.1016/s1473-3099(03)00671-6.
7
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.美国胸科学会/疾病控制与预防中心/美国传染病学会:结核病的治疗
Am J Respir Crit Care Med. 2003 Feb 15;167(4):603-62. doi: 10.1164/rccm.167.4.603.
8
Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice.莫西沙星单独及与其他抗菌药物联合应用对BALB/c小鼠耐多药结核分枝杆菌感染的活性。
Antimicrob Agents Chemother. 2003 Jan;47(1):360-2. doi: 10.1128/AAC.47.1.360-362.2003.
9
Characterization of pyrazinamide and ofloxacin resistance among drug resistant Mycobacterium tuberculosis isolates from Singapore.
Int J Infect Dis. 2002 Mar;6(1):48-51. doi: 10.1016/s1201-9712(02)90136-0.
10
Fluoroquinolones and tuberculosis.氟喹诺酮类药物与结核病
Expert Opin Investig Drugs. 2002 Feb;11(2):233-58. doi: 10.1517/13543784.11.2.233.